REASSESSMENT OF THE CONCEPT OF A THERAPEUTIC RANGE OF ANTICONVULSANT PLASMA LEVELS
- 1 October 1983
- journal article
- review article
- Published by Wiley in Developmental Medicine and Child Neurology
- Vol. 25 (5) , 660-671
- https://doi.org/10.1111/j.1469-8749.1983.tb13829.x
Abstract
The significance of plasma-level measurements of anti-epileptic drugs is reviewed, especially as it applies to the treatment of childhood epilepsy. The problems associated with the determination and interpretation of 'therapeutic' levels are discussed, including the justification of applying to children the results of studies of adults. It is concluded that plasma-level determinations are of great value in specific circumstances, but that more study is needed to take into account the multiplicity of variables involved.Keywords
This publication has 88 references indexed in Scilit:
- The effect of acetylsalicylic acid on serum free valproate concentrations and valproate clearance in childrenThe Journal of Pediatrics, 1982
- Diurnal Variations in Steady-state Plasma Concentrations of Valproic Acid in Epileptic PatientsClinical Pharmacokinetics, 1982
- Neuronal deficits after neonatal exposure to phenobarbitalExperimental Neurology, 1981
- Concentration of Metabolites of Valproic Acid in Plasma of Epileptic PatientsEpilepsia, 1981
- INFLUENCE OF PHENOBARBITAL ON THE PSYCHOMOTOR DEVELOPMENT AND BEHAVIOUR IN PRESCHOOL CHILDREN WITH CONVULSIONS1Neuropediatrics, 1980
- Phenobarbital and diphenylhydantoin levels inneonates with seizuresThe Journal of Pediatrics, 1978
- Clinical Pharmacokinetics of CarbamazepineClinical Pharmacokinetics, 1978
- Sodium ValproateDrugs, 1977
- Diphenylhydantoin: Efficacy, toxicity, and dose-serum level relationships in childrenThe Journal of Pediatrics, 1972
- The neurologic hazards ofdiphenylhydantoin in childhoodThe Journal of Pediatrics, 1968